Blood-brain barrier breakdown in cold-injured brain is linked to a biphasic stimulation of ornithine decarboxylase activity and polyamine synthesis: both are coordinately inhibited by verapamil, dexamethasone, and aspirin.
An early increase in ornithine decarboxylase (ODC) activity and polyamine levels in rat cerebral capillaries was previously implicated in the mediation of blood-brain barrier (BBB) breakdown in cold-injured brain. A time course study in rat cerebrum indicated that cold injury evokes a biphasic increase in ODC activity and polyamine levels in perilesional cortex. ODC activity rose sharply (fourfold) within 1 min, remained elevated for 5 min, and then returned to the basal level by 10 min. A transient rise in polyamine concentration followed in the rank order of putrescine greater than spermidine greater than spermine. A secondary rise in ODC activity commenced in perilesional tissue at 2-6 h and peaked (8.8-fold) at 48 h. Major increases in the content of putrescine (330%), spermidine (103%), and spermine (50%) developed at 48-72 h. alpha-Difluoromethylornithine (DFMO), a specific irreversible inhibitor of ODC, suppressed the evoked increase in ODC activity and abolished the associated increase in content of polyamines, findings indicating that the accumulation of polyamines in cryoinjured brain reflects enhanced synthesis resulting from an ODC-mediated increase in putrescine content. Cycloheximide and actinomycin D were without effect on the early increase in ODC activity but inhibited the delayed increase in ODC activity, an observation suggesting that the initial increase in activity reflects an activation of a cryptic ODC via a posttranslational process, whereas the delayed increase in activity results from ODC synthesis mainly under transcriptional control.(ABSTRACT TRUNCATED AT 250 WORDS)
Koenig
H
H
Neurology Service, V.A. Lakeside Medical Center, Chicago, Illinois 60611.
Goldstone
A D
AD
Lu
C Y
CY
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D001930:Brain Injuries / Q000201:enzymology* / Q000378:metabolism; D003080:Cold Temperature; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology*; D000518:Eflornithine / Q000494:pharmacology; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D011073:Polyamines / Q000096:biosynthesis*; D051381:Rats; D011919:Rats, Inbred Strains; D014700:Verapamil / Q000494:pharmacology*
D011073:Polyamines; D003609:Dactinomycin; D003907:Dexamethasone; D003513:Cycloheximide; D014700:Verapamil; D009955:Ornithine Decarboxylase; D001241:Aspirin; D000518:Eflornithine